Abstract
The control of spontaneous and postoperative hemorrhage from the nose and throat is a matter of concern to the otolaryngologist and the patient alike. In some instances the control of bleeding from these areas may be a relatively simple matter limited to some topical therapeutic procedure. On other occasions the patient's course may dictate more radical and even life-saving measures. In either event, any therapeutic agent or procedure which facilitates control of hemorrhage is a welcome addition to the otolaryngologist's therapeutic armamentarium. In past years efforts have been concentrated primarily on the production of substances calculated to act on the blood-clotting mechanism, either by systemic administration or by local application. Such of these agents as I have employed have afforded rather poor results for the most part, and recourse to more time-honored, but troublesome, methods has been the usual rule. There now appears on the horizon a new product which